1971
DOI: 10.1111/j.1749-6632.1971.tb45273.x
|View full text |Cite
|
Sign up to set email alerts
|

Cyclic Amp and Smooth Muscle Function*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
68
0

Year Published

1973
1973
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 209 publications
(73 citation statements)
references
References 16 publications
5
68
0
Order By: Relevance
“…In this paper, we observed that the vascular relaxant effect of histamine in the same preparation is greatly potentiated by papaverine and IBMX, two potent phosphodiesterase inhibitors (Triner et al, 1971;Wells, Wu, Baird & Hardman, 1975), and inhibited dose-dependently by verapamil, a well known inhibitor of Ca2+ influx into contractile organs (Fleckenstein, 1977). The potentiation of histamine-induced vascular relaxation by papaverine Table 2 Table 1. and IBMX constitute indirect evidence for the participation of intracellular cyclic AMP in the vascular relaxant effect of histamine.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…In this paper, we observed that the vascular relaxant effect of histamine in the same preparation is greatly potentiated by papaverine and IBMX, two potent phosphodiesterase inhibitors (Triner et al, 1971;Wells, Wu, Baird & Hardman, 1975), and inhibited dose-dependently by verapamil, a well known inhibitor of Ca2+ influx into contractile organs (Fleckenstein, 1977). The potentiation of histamine-induced vascular relaxation by papaverine Table 2 Table 1. and IBMX constitute indirect evidence for the participation of intracellular cyclic AMP in the vascular relaxant effect of histamine.…”
Section: Discussionmentioning
confidence: 75%
“…The precise molecular mechanism by which vasodilators produce their effect has not yet been elucidated. However, current hypothesis suggest that adenosine cyclic 3',5'-monophosphate (cyclic AMP) may be the intracellular mediator of several 0007-1 188/80/100219-09 $01.00 vasodilators (Triner, Nahas, Vulliemoz, Overweg, Verosky, Habif & Ngai, 1971; Andersson, 1972). The intracellular accumulation of cyclic AMP induced by drugs which activate adenylate cyclase or inhibit tissue phosphodiesterases, would contribute to Ca2 + sequestration in, and/or Ca2 + extrusion from, the smooth muscle cells (Andersson, 1972;Rasmussen, 1976).…”
Section: Introductionmentioning
confidence: 99%
“…The potentiation of glucagon by Indo, a well known inhibitor of prostaglandin synthesis (Vane, 1971) may also be explained by the ability of this drug to inhibit phosphodiesterases (Flores & Sharp, 1972;Newcombe, Thanassi & Ciosek Jr., 1974). Since phosphodiesterase inhibitors are known to favour the intracellular accumulation of cyclic AMP in various organs including vascular tissues (Triner et al, 1971;Andersson, 1972) by blocking the enzymatic conversion of cyclic AMP to 5'-AMP, they may also potentiate the vascular relaxant effect of glucagon by such a mechanism. If this interpretation is correct, we would expect the vasodilator effect of exogenous cyclic AMP to be affected in a similar way to glucagon by these drugs.…”
Section: Discussionmentioning
confidence: 99%
“…An age-related decrease in adenosine-induced relaxations has also been observed in isolated aortae from 30 to 360 days old rabbits . Adenosine 3', 5'-cyclic monophosphate (cyclic AMP) has been proposed as a mediator for the relexation ofvascular smooth muscle elicited by isoprenaline (Triner et al, 1971;Volicer & Hynie, 1971;Andersson, 1973), adenosine (Kukovetz et al, 1978) and PGI2 (Kukovetz et al, 1979). …”
Section: Discussionmentioning
confidence: 99%